Nutrition, dietary interventions and prostate cancer: the latest evidence

被引:0
作者
Pao-Hwa Lin
William Aronson
Stephen J Freedland
机构
[1] Duke University Medical Center,Department of Medicine, Division of Nephrology
[2] Veterans Affairs Greater Los Angeles Healthcare System,Urology Section, Department of Surgery
[3] UCLA School of Medicine,Department of Urology
[4] Division of Urology,Urology Section, Department of Surgery, Durham Veterans Affairs Medical Center
[5] Duke Prostate Center,undefined
[6] Departments of Surgery and Pathology,undefined
[7] Duke University Medical Center,undefined
来源
BMC Medicine | / 13卷
关键词
Diet; Prostate cancer; Nutrients; Dietary pattern; Lifestyle; Prevention; Treatment; Nutrition; Dietary intervention; Review;
D O I
暂无
中图分类号
学科分类号
摘要
Prostate cancer (PCa) remains a leading cause of mortality in US men and the prevalence continues to rise world-wide especially in countries where men consume a ‘Western-style’ diet. Epidemiologic, preclinical and clinical studies suggest a potential role for dietary intake on the incidence and progression of PCa. 'This minireview provides an overview of recent published literature with regard to nutrients, dietary factors, dietary patterns and PCa incidence and progression. Low carbohydrates intake, soy protein, omega-3 (w-3) fat, green teas, tomatoes and tomato products and zyflamend showed promise in reducing PCa risk or progression. A higher saturated fat intake and a higher β-carotene status may increase risk. A ‘U’ shape relationship may exist between folate, vitamin C, vitamin D and calcium with PCa risk. Despite the inconsistent and inconclusive findings, the potential for a role of dietary intake for the prevention and treatment of PCa is promising. The combination of all the beneficial factors for PCa risk reduction in a healthy dietary pattern may be the best dietary advice. This pattern includes rich fruits and vegetables, reduced refined carbohydrates, total and saturated fats, and reduced cooked meats. Further carefully designed prospective trials are warranted.
引用
收藏
相关论文
共 1391 条
[31]  
Lloyd JC(2012)A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom Cancer Causes Control 23 907-178
[32]  
Phillips TE(2013)Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer Prostate 73 986-1689
[33]  
Poulton SH(2013)Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial JAMA 310 170-E130
[34]  
Dewhirst MW(2013)Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR PLoS One 8 e70372-436S
[35]  
Pizzo SV(2013)Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells Prostate 73 1681-3250
[36]  
Freedland SJ(2014)Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials BJU Int 113 E119-1654
[37]  
Drake I(2013)Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial PLoS One 8 e68331-82
[38]  
Sonestedt E(2014)Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis Am J Clin Nutr 100 431S-1171
[39]  
Gullberg B(2014)Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells Endocrinology 155 3238-2257
[40]  
Ahlgren G(2014)Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells Br J Cancer 110 1645-2147